ArticleTranslational oncology2026

First functional evidence that a rare germline TP53β variant drives senescence-associated immune suppression and impairs apoptosis and cell migration in breast cancer patients.

Claudia Christowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.